Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- Countryside Properties withdraws guidance, suspends dividend
25 Mar 2020 - Countryside Properties Suspends Dividend Amid Construction Halt
25 Mar 2020 - Housebuilders are too cheap, Jefferies says
19 Mar 2020 - UK BROKER RATINGS SUMMARY: Jefferies Ups Taylor Wimpey, Barratt To Buy
19 Mar 2020 - Strong Mid-Cap Performance Helps Murray Income Trust Beat Benchmark
17 Feb 2020 - DIRECTOR DEALINGS: Countryside Properties Executive Kelly Sells Shares
5 Feb 2020 - UK Dividends Calendar - Next 7 Days
31 Jan 2020 - Countryside delivers decent start to new financial year
23 Jan 2020
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
Countryside Properties withdraws guidance, suspends dividend
(Sharecast News) - Countryside Properties withdrew its guidance for the current financial year and suspended its dividend on Wednesday due to the Covi...
Countryside Properties Suspends Dividend Amid Construction Halt
Countryside Properties Suspends Dividend Amid Construction Halt
Housebuilders are too cheap, Jefferies says
(Sharecast News) - UK housebuilders are too cheap, Jefferies said as the broker placed 'buy' ratings on almost all sector stocks after big share price...
UK BROKER RATINGS SUMMARY: Jefferies Ups Taylor Wimpey, Barratt To Buy
UK BROKER RATINGS SUMMARY: Jefferies Ups Taylor Wimpey, Barratt To Buy
Strong Mid-Cap Performance Helps Murray Income Trust Beat Benchmark
Strong Mid-Cap Performance Helps Murray Income Trust Beat Benchmark
DIRECTOR DEALINGS: Countryside Properties Executive Kelly Sells Shares
DIRECTOR DEALINGS: Countryside Properties Executive Kelly Sells Shares
Countryside delivers decent start to new financial year
(Sharecast News) - Mixed-tenure developer Countryside Properties updated the market on its trading in the first quarter on Thursday, describing it as ...
Follow the stocks
